Eaton Vance Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$5.51M Sell
139,396
-57
-0% -$2.52K 0.01% 749
2022
Q2
$6.14M Buy
139,453
+8,520
+7% +$368K 0.01% 750
2022
Q1
$5.22M Buy
130,933
+26,701
+26% +$951K 0.01% 874
2021
Q4
$4.19M Buy
104,232
+47
+0% +$1.75K 0.01% 824
2021
Q3
$4.24M Sell
104,185
-48
-0% -$2.01K 0.01% 757
2021
Q2
$4.73M Buy
104,233
+9,158
+10% +$405K 0.01% 799
2021
Q1
$3.96M Buy
95,075
+1,137
+1% +$51.9K 0.01% 802
2020
Q4
$4.01M Buy
93,938
+17
+0% +$611 0.01% 769
2020
Q3
$2.47M Buy
93,921
+81,579
+661% +$2.27M ﹤0.01% 790
2020
Q2
$331K Hold
12,342
﹤0.01% 1172
2020
Q1
$222K Hold
12,342
﹤0.01% 1203
2019
Q4
$219K Buy
12,342
+342
+3% +$5.92K ﹤0.01% 1270
2019
Q3
$186K Hold
12,000
﹤0.01% 1260
2019
Q2
$206K Hold
12,000
﹤0.01% 1254
2019
Q1
$193K Hold
12,000
﹤0.01% 1209
2018
Q4
$176K Hold
12,000
﹤0.01% 1150
2018
Q3
$218K Hold
12,000
﹤0.01% 1164
2018
Q2
$202K Sell
12,000
-12,000
-50% -$227K ﹤0.01% 1158
2018
Q1
$470K Buy
+24,000
New +$465K ﹤0.01% 1110

Other funds holding HALO

Eaton Vance Management's HALO Position: Q3 2022 in Review

Eaton Vance Management reduced its Halozyme (HALO) stake by 0.04% in Q3 2022, selling an estimated $2.52K and leaving 139,396 shares worth $5.51M. The position accounts for 0.01% of the portfolio, ranked #749.

Eaton Vance Management first reported a position in HALO in Q1 2018 and has held it in 19 quarters since. The position peaked at $6.14M in Q2 2022. 357 funds tracked by Wall St. Rank hold HALO as of Q3 2022.

  • Eaton Vance Management held 139,396 shares of Halozyme worth $5.51M as of Q3 2022.
  • Eaton Vance Management sold 57 Halozyme shares in Q3 2022, an estimated $2.52K.
  • Halozyme made up 0.01% of Eaton Vance Management's portfolio in Q3 2022, its #749 holding.
  • Eaton Vance Management first reported a position in Halozyme in Q1 2018 and has held it in 19 quarters since.
  • Eaton Vance Management's Halozyme position peaked at $6.14M in Q2 2022.
  • 357 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.